Figure 1.
Increased frequency of CD41 expressing Mk-biased HSCs in mutant JAK2-expressing mice. (A) Frequencies (left) and percentages (right) of CD41hi and CD41lo HSCs within the phenotypic HSC compartment in BM in the indicated genotypes (n = 7 mice per genotype). Frequencies (left) and percentages (right) of CD41hi and CD41lo HSCs in the phenotypic HSC compartment in the spleen of the indicated genotype (n = 7 mice per genotype). (B) Analysis of colonies grown from a FACS-sorted single CD41hi or CD41lo HSC in liquid culture showing the percentages of colonies containing Mk (CD41+), myeloid (CD16+), or mixed (Mk and myeloid, CD41+/CD16+) cells after 10 days of culture. We plated 48 single HSCs per mouse with 3 mice per genotype in 384-well plates (ie, a total of 144 single cells per genotype) and scored each well separately after 10 days of culture. (C) Setup of transplantations with purified CD41hi and CD41lo HSC subsets into lethally irradiated recipients (n = 6 mice per cell type and genotype). Data show peripheral blood counts in recipients of CD41hi or CD41lo HSCs (top row) and donor chimerism determined as a percentage of GFP+ cells in PB (bottom row). Spleen weights of CD41hi and CD41lo HSC transplant-recipient mice at 24 weeks after transplantation are shown (top right graph). Group size: n = 6 mice per cell type and genotype. (D) Analysis of donor chimerism (percentage of GFP+ cells) in progenitor and stem cells in BM and spleen in CD41hi and CD41lo HSC transplant recipients at 24 weeks after transplantation (n = 6 mice per cell type and genotype). (E) Analysis of recipients of CD41lo HSC transplants. Stacked bar graph shows percentages of CD41lo and CD41hi HSCs in the GFP+ subset of LT-HSCs. One- or 2-way analyses of variance followed by Tukey’s multiple-comparisons test were used for multiple-group comparisons. All data are means ± standard error of the mean. *P < .05; **P < .01; ***P < .001; ****P < .0001.

Increased frequency of CD41 expressing Mk-biased HSCs in mutant JAK2-expressing mice. (A) Frequencies (left) and percentages (right) of CD41hi and CD41lo HSCs within the phenotypic HSC compartment in BM in the indicated genotypes (n = 7 mice per genotype). Frequencies (left) and percentages (right) of CD41hi and CD41lo HSCs in the phenotypic HSC compartment in the spleen of the indicated genotype (n = 7 mice per genotype). (B) Analysis of colonies grown from a FACS-sorted single CD41hi or CD41lo HSC in liquid culture showing the percentages of colonies containing Mk (CD41+), myeloid (CD16+), or mixed (Mk and myeloid, CD41+/CD16+) cells after 10 days of culture. We plated 48 single HSCs per mouse with 3 mice per genotype in 384-well plates (ie, a total of 144 single cells per genotype) and scored each well separately after 10 days of culture. (C) Setup of transplantations with purified CD41hi and CD41lo HSC subsets into lethally irradiated recipients (n = 6 mice per cell type and genotype). Data show peripheral blood counts in recipients of CD41hi or CD41lo HSCs (top row) and donor chimerism determined as a percentage of GFP+ cells in PB (bottom row). Spleen weights of CD41hi and CD41lo HSC transplant-recipient mice at 24 weeks after transplantation are shown (top right graph). Group size: n = 6 mice per cell type and genotype. (D) Analysis of donor chimerism (percentage of GFP+ cells) in progenitor and stem cells in BM and spleen in CD41hi and CD41lo HSC transplant recipients at 24 weeks after transplantation (n = 6 mice per cell type and genotype). (E) Analysis of recipients of CD41lo HSC transplants. Stacked bar graph shows percentages of CD41lo and CD41hi HSCs in the GFP+ subset of LT-HSCs. One- or 2-way analyses of variance followed by Tukey’s multiple-comparisons test were used for multiple-group comparisons. All data are means ± standard error of the mean. *P < .05; **P < .01; ***P < .001; ****P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal